RBF Capital, LLC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q4 2014. The put-call ratio across all filers is 3.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
RBF Capital, LLC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q2 2019$25,000
-41.9%
14,892
-0.7%
0.00%
-40.0%
Q1 2019$43,000
+26.5%
15,0000.0%0.01%
+25.0%
Q4 2018$34,000
-43.3%
15,0000.0%0.00%
-42.9%
Q3 2018$60,000
-20.0%
15,0000.0%0.01%
-22.2%
Q2 2018$75,000
-2.6%
15,0000.0%0.01%0.0%
Q1 2018$77,0000.0%15,0000.0%0.01%
+12.5%
Q4 2017$77,000
-8.3%
15,0000.0%0.01%
-27.3%
Q3 2017$84,000
-6.7%
15,0000.0%0.01%
-8.3%
Q2 2017$90,000
+1.1%
15,0000.0%0.01%0.0%
Q1 2017$89,000
-14.4%
15,0000.0%0.01%
-20.0%
Q4 2016$104,000
-47.5%
15,0000.0%0.02%
-55.9%
Q3 2016$198,000
+16.5%
15,0000.0%0.03%0.0%
Q2 2016$170,000
-2.9%
15,0000.0%0.03%0.0%
Q1 2016$175,000
-0.6%
15,0000.0%0.03%
+3.0%
Q4 2015$176,000
+2.3%
15,0000.0%0.03%
-8.3%
Q3 2015$172,000
-36.5%
15,0000.0%0.04%
-29.4%
Q2 2015$271,000
-6.2%
15,0000.0%0.05%
-13.6%
Q1 2015$289,000
+9.9%
15,0000.0%0.06%
+9.3%
Q4 2014$263,000
-4.0%
15,0000.0%0.05%
-14.3%
Q3 2014$274,000
-20.6%
15,0000.0%0.06%
-24.1%
Q2 2014$345,000
-5.0%
15,0000.0%0.08%
-6.7%
Q1 2014$363,000
-3.7%
15,0000.0%0.09%0.0%
Q4 2013$377,000
+15.6%
15,0000.0%0.09%
+2.3%
Q3 2013$326,000
+28.9%
15,0000.0%0.09%
+20.8%
Q2 2013$253,00015,0000.07%
Other shareholders
TRINITY BIOTECH PLC shareholders Q4 2014
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 639,291$14,723,000,0006.49%
ACK Asset Management 684,655$15,768,0004.74%
GOLDMAN CAPITAL MANAGEMENT INC 304,690$7,017,0003.48%
Paradice Investment Management LLC 239,138$5,507,0001.64%
Park West Asset Management LLC 520,770$11,993,0001.56%
RK Capital 323,279$7,445,0001.48%
Adirondack Research & Management Inc. 184,638$4,252,0001.44%
CARDINAL CAPITAL MANAGEMENT LLC /CT 861,625$19,843,0001.07%
Pier Capital, LLC 251,917$5,802,0000.82%
Benchmark Capital Advisors 56,954$1,312,0000.82%
View complete list of TRINITY BIOTECH PLC shareholders